Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-24T07:34:11.238Z Has data issue: false hasContentIssue false
  • English
  • Français

Use of lidocaine with phenylephrine (Co-phenylcaine) spray for anaesthesia of the external auditory canal

Published online by Cambridge University Press:  22 January 2021

A E Lim ,
A Alatsatianos  and
P Wardrop
A E Lim*
Affiliation:
Crosshouse University Hospital, Kilmarnock, Scotland, UK
A Alatsatianos
Affiliation:
Crosshouse University Hospital, Kilmarnock, Scotland, UK
P Wardrop
Affiliation:
Crosshouse University Hospital, Kilmarnock, Scotland, UK
*
Author for correspondence: Dr Alison Lim, Crosshouse University Hospital, Kilmarnock KA2 0BE, Scotland, UK E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective

A method is described for topical local anaesthesia of the tympanic membrane and ear canal using lidocaine and phenylephrine (Co-phenylcaine) spray and soaked micropatties.

Discussion

The advantages of this method are discussed in comparison to existing methods.

Keywords

Ear CanalAnesthetics, Local
Type
Short Communications
Information
The Journal of Laryngology & Otology , Volume 135 , Issue 1 , January 2021 , pp. 80 - 82
Copyright
Copyright © The Author(s), 2021. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Dr A Lim takes responsibility for the integrity of the content of the paper

References

Weinberg, L, Peake, B, Tan, C, Nikfarjam, M. Pharmacokinetics and pharmacodynamics of lignocaine: a review. World J Anesthesiol 2015;4:17–29CrossRefGoogle Scholar
EMC. Lidocaine Hydrochloride 5% w/v and Phenylephrine Hydrochloride 0.5% w/v Topical Solution. In: https://www.medicines.org.uk/emc/product/3592/smpc#PHARMACOLOGICAL_PROPS [4 December 2020]Google Scholar
Emla Cream (lidocaine 2.5% and Prilocaine 2.5%). In: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019941s021lbl.pdf [4 December 2020]Google Scholar